Alisha Q. Nanda’s practice involves a wide range of complex commercial, securities, insurance and regulatory matters. Ms. Nanda has litigated in state and federal trial and appellate courts around the United States and has been involved in regulatory investigations, arbitrations and mediations.

Bio

Ms. Nanda’s experience includes representing:

  • a pharmaceutical company and certain of its officers and directors in a putative securities class action and a related derivative suit following the FDA’s disclosure of safety events relating to an approved drug;
  • a health care technology company and certain of its officers and directors in a securities class action alleging violations of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 in connection with its February 2015 initial public offering; a related derivative suit was dismissed;
  • a pharmaceutical company and certain of its officers and directors in securing the dismissal of a putative securities class action claiming that, in the months leading up to the company’s announcement that it would file voluntary Chapter 11 petitions, the company’s public filings contained material misrepresentations and omissions concerning its cash projections and the board’s evaluation of strategic alternatives;
  • a mutual life insurance company in a purported class action lawsuit challenging the company’s calculation of the amount of surplus it may retain as a “safety fund” under Massachusetts law;
  • a company in SEC investigations concerning suspicious activity reporting under the Bank Secrecy Act;
  • an investment bank in a purported class action lawsuit in the District of Massachusetts involving antitrust claims concerning a number of complex leveraged buyout transactions over a multi-year period, which resulted in the dismissal of all claims on summary judgment;
  • a mutual life insurance company in a purported class action lawsuit challenging a proxy regarding bylaw amendments and demanding inspection of “books and records,” which resulted in the dismissal of all claims and subsequently was affirmed by the Appeals Court of Massachusetts;
  • an insurance company in dismissing a purported class action lawsuit alleging that the company breached its contractual duties to variable annuity and variable life insurance policyholders by implementing a volatility management strategy in certain portfolios;
  • an investment adviser in a lawsuit brought by a state employees’ retirement system involving allegations of improper “market timing” trading in mutual funds, which resulted in the dismissal of all claims on summary judgment and subsequently was affirmed by a Texas state court of appeals; and
  • an insurance company in an appeal before the Eighth Circuit Court of Appeals involving a reinsurance policy and the legal doctrine of “follow-the-fortunes,” which resulted in a complete victory for the client.

Credentials

Education

  • J.D., Harvard Law School, 2003 (member, Harvard Law Review)
  • A.B., Harvard University, Harvard College, 1999 (magna cum laude)

Admissions

  • Massachusetts
  • New York

Experience

  • Law Clerk, Hon. William G. Young, U.S. District Court for the District of Massachusetts (2004)

Alisha Q. Nanda